Zurit Levine
Chief Tech/Sci/R&D Officer at COMPUGEN LTD.
Zurit Levine active positions
| Companies | Position | Start | End |
|---|---|---|---|
| COMPUGEN LTD. | Chief Tech/Sci/R&D Officer | 2017-12-31 | - |
| Corporate Officer/Principal | 1998-12-31 | 2017-12-31 |
Career history of Zurit Levine
Former positions of Zurit Levine
| Companies | Position | Start | End |
|---|---|---|---|
Therapeutic Discovery Corp.
 Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA. | Director/Board Member | - | 2006-12-31 |
Neviah Genomics Ltd.
 Neviah Genomics Ltd. Pharmaceuticals: MajorHealth Technology Neviah Genomics Ltd. develops novel biomarkers for the prediction of drug-induced toxicity. It identifies biomarkers for the prediction of drug-induced toxicity. The firm offers involving cell harvest and culture, compound exposure, mRNA expression analysis and multi-parameter mathematical computation. The company was founded in 2012 and is headquartered in Yavne, Israel. | Director/Board Member | - | - |
Training of Zurit Levine
| Tel-Aviv University | Doctorate Degree |
Statistics
International
| Israel | 4 |
| United States | 2 |
Operational
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Therapeutic Discovery Corp.
Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA. | Health Technology |
Neviah Genomics Ltd.
Neviah Genomics Ltd. Pharmaceuticals: MajorHealth Technology Neviah Genomics Ltd. develops novel biomarkers for the prediction of drug-induced toxicity. It identifies biomarkers for the prediction of drug-induced toxicity. The firm offers involving cell harvest and culture, compound exposure, mRNA expression analysis and multi-parameter mathematical computation. The company was founded in 2012 and is headquartered in Yavne, Israel. | Health Technology |
- Stock Market
- Insiders
- Zurit Levine
- Experience